-
Devalla, HD, Schwach, V, Ford, JW, Milnes, JT, El-Haou, S, Jackson, C, Gkatzis, K, Elliott, DA, Chuva de Sousa Lopes, SM, Mummery, CL, et al.
Atrial-like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial-selective pharmacology..
EMBO Mol Med
7(4)
:
394 -410
2015
view publication
-
Laco, F, Low, J-L, Seow, J, Woo, TL, Zhong, Q, Seayad, J, Liu, Z, Wei, H, Reuveny, S, Elliott, DA, et al.
Cardiomyocyte differentiation of pluripotent stem cells with SB203580 analogues correlates with Wnt pathway CK1 inhibition independent of p38 MAPK signaling..
J Mol Cell Cardiol
80:
56 -70
2015
view publication
-
Den Hartogh, SC, Schreurs, C, Monshouwer-Kloots, JJ, Davis, RP, Elliott, DA, Mummery, CL, Passier, R.
Dual reporter MESP1 mCherry/w-NKX2-5 eGFP/w hESCs enable studying early human cardiac differentiation..
Stem Cells
33(1)
:
56 -67
2015
view publication
-
Lagerqvist, EL, Finnin, BA, Elliott, DA, Anderson, DJ, Wu, SM, Pouton, CW, Haynes, JM.
Comparing mouse and human pluripotent stem cell derived cardiac cells: Both systems have advantages for pharmacological and toxicological screening..
J Pharmacol Toxicol Methods
74:
17 -25
2015
view publication
-
Arasaratnam, D, Elliott, D, White, T.
The distinctive micro-RNA expression signature of human embryonic stem cell-derived cardiomyocytes.
Heart Lung and Circulation
24:
s183
2015
view publication